[29P01-234] The comparison of the Food for Specified Health Use and Foods with Functional Claims belonging to the same category

○Mitsuo Saito^1,2, Yuzuru Hayashi¹ (1. Institute for Health Vigilance, 2. Japan Pharmaceutical Information Center)

[29P01-235] Examination of extraction methods and analytical methods of cannabinoids from marijuana edibles

○Wako Sugeta¹, Hideyo Date¹, Yasuhiro Tomioka², Harue Hiramoto³ (1. Hiroshima Prefectural Technology Research Institute, Public Health and Environment Center, 2. Narcotics Control Department, Shikoku Regional Bureau of Health and Welfare, 3. Hiroshima Prefectural Health and Welfare Affairs Bureau, Pharmaceutical Division)

[29P01-236] In vitro monoamine transporter (MAT) inhibition assay for the psychoactive substances, 2018-2020

○Yasushi Ono¹, Kuniaki Tayama¹, Jin Suzuki¹, Toshinari Suzuki¹, Akiko Inomata¹, Takako Moriyasu¹ (1. Tokyo Metropolitan Institute of Public Health)

[29P01-237] Evaluation of rapid detection kits of stimulants in terms of the false responses

○Suguru Nabeya¹, Noriyuki Suzuki¹, Hirotaro Iwase^2,3, Yasumitsu Ogura¹ (1. Grad. Sch. Pharm. Sci., Chiba Univ., 2. Grad. Sch. Med., Univ. Tokyo, 3. Edu. Res. Center Legal Med., Chiba Univ.)

[29P01-238] Synthesis and analytical characterization of the LSD analogue N-methyl-N-isopropyl lysergamide (MiPLA)

○Takuji Shoda¹, Maiko Kawamura¹, Ruri Hanajiri-Kikura¹, Takashi Hakamatsuka¹, Yosuke Demizu¹ (1. National Institute of Health Sciences)

[29P01-239] Investigation for practical applications of the method to screen hallucinogens by observation of the head twitch response (HTR) in mice

○Mari Nakamura¹, Masao Yoshida¹, Fujifumi Kaihoko¹, Kyouko Hiramatsu¹, Yoshikazu Kubo¹, Hiroshi Andou¹, Jin Suzuki¹, Toshinari Suzuki¹, Akiko Inomata¹, Takako Moriyasu¹ (1. Tokyo Metropolitan Institute of Public Health)

[29P01-240] Investigation of attitudes toward caffeine intake of junior high school students.

○masahiro namiki¹, Daisuke Kobayashi², Nozomi Kitahara³, Kunihiko Matsui⁴, Masashi Ichinowatari⁵, Mamoru Maeda⁶, Yoshitaka Hasegawa⁶, Ryota Tsukioka⁶, Azusa Morisawa⁶, Miya Oishi⁶ (1. AIN Pharmacy NOHEJI, AIN PHARMACIEZ INC., 2. AIN Pharmacy YOKOTE, AIN PHARMACIEZ INC., 3. AIN Pharmacy MIYAKOYAMAGUCHI, AIN PHARMACIEZ INC., 4. Miyako Pharmacy, MIYAKO AIN INC., 5. AIN PHARMACIEZ INC., 6. AIN HOLDINGS INC.)

[29P01-241] Determination of vaporized constitute of E-liquid containing Caffeine produced by Electronic Cigarette.

○Fumiaki Sotodate¹, Takahiro Iwahashi¹, Kenichi Kumasaka¹ (1. Kanagawa.Pref.Institute of Public Health)

[29P01-242] Development of LC-MS/MS assay for vaporized caffeine

○Makoto Takada¹, Hajime Harada², Junpei Mutoh¹, Naoya Kishikawa³, Takashi Kitahara², Naotaka Kuroda³, Mitsuhiro Wada¹ (1. Sch. Pharm. Sci., Sanyo-onoda City Univ., 2. Department of Pharm., Yamaguchi Univ. Hospital, 3. Grad. Sch. Biomed. Sci., Nagasaki Univ.)

[29P01-243] Health Education by School Pharmacists - Report of Secondary School Girls Teaching.

○Maki Shimizu^1,2, Yoshiko Imai², Kenji Narusuye¹, Michiko Goroumaru-Shinkai¹ (1. Pharm. Sci., Toho Univ., 2. Miyama SS, Funabashi City.)

[29P01-244] Actual conditions regarding motion sickness by video game : From consumer survey results

○Osamu Morimoto¹, Katsumi Saito¹, Kentaro Matsuura¹ (1. CHC medical SSP CO.,LTD.)

[29P01-245] Examination of ventilation in the classroom which assumes carbon dioxide concentration an index in COVID-19 epidemic

○Haruko Haga¹, Atuko Sase¹, Satiko Saito¹, Shigemi Takagi¹ (1. Asahi city School Pharmacist Association)

Session information

[29P01] 社会と薬学